Hormone replacement therapy for prevention in postmenopausal women. The end of controversy?;Terapéutica hormonal sustitutiva como prevención en la posmenopausia: ¿Fin de la controversia?

Medicina Clinica

Volumn 119, Issue 11, 2002, Pages 416-417

  Balasch, Juan ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; ALZHEIMER DISEASE; BREAST CANCER; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; EDITORIAL; FEMALE; HORMONE SUBSTITUTION; HUMAN; LUNG EMBOLISM; OSTEOPOROSIS; POSTMENOPAUSE; PROPHYLAXIS;

EID: 0037027218     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(02)73437-4     Document Type: Editorial

References (15)

1. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's health initiative randomized controlled trial. JAMA 2002;288:321-33.
2. Petitti DB. Hormone replacement therapy for prevention: more evidence, more pessimism. JAMA 2002;288:99-101.
3. Vastag B. Hormone replacement therapy falls out of favor with expert committee. JAMA 2002;287:1923-4.
4. Fletcher SW, Colditz GA. Failure of estrogen plus progesting therapy for prevention. JAMA 2002;288:366-8.
5. Balasch J. Terapéutica hormonal sustitutiva en la postmenopausia: beneficios, riesgos e incerticumbres. Med Integral 1996;27:313-5.
6. American College of Physicians. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Inter Med 1992;117:1038-41.
7. Clinical Synthesis Panel on HRT. Hormone replacement therapy. Lancet 1999;354:152-5.
8. Santoro NF, Col NF, Eckman MH, Wong JB, Pauker SG, Cauly JA, et al. Hormone replacement therapy - Where are we going? J Clin Endocrinol Metab 1999;84:1798-812.
9. Newton KM, Lacroix AZ, Leveille SG, Rutter C, Keenan NL, Anderson LA. The physician's role in women's decision making about hormone replacement therapy. Obstet Gynecol 1998;92:580-4.
10. Friedrich MJ. Recent studies bring risks, benefits of hormone replacement therapy under scrutiny. J Natl Cancer Inst 2001;97:1287-8.
11. Grady D, Cummings SR. Postmenoupausal hormone therapy for prevention of fractures: How good is the evidence? JAMA 2001;285:2909-10.
12. Dixon JM. Hormone replacement therapy and the breast: We should worry about the increase in the risk of breast cancer. Br Med J 2001;323:1381-2.
13. Rexrode KM, Manson JE. Postmenopausal hormone therapy and quality of life: No cause for celebration. JAMA 2002;287:641-2.
14. Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and estrogen/progestin replacement study follow-up (HERS II). JAMA 2002;288:49-57.
15. Hulley S, Furberg C, Barret-Connor E, Cauley J, Grady D, Haskell W, et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and estrogen/progestin replacement study follow-up (HERS II). JAMA 2002;288:58-66.